Quantification of coronary flow reserve in patients with ischaemic and non-ischaemic cardiomyopathy and its association with clinical outcomes.
about
Coronary Microvascular Function and Beyond: The Crosstalk between Hormones, Cytokines, and NeurotransmittersMyocardial blood flow assessment with 82rubidium-PET imaging in patients with left bundle branch block.Clinical use of quantitative cardiac perfusion PET: rationale, modalities and possible indications. Position paper of the Cardiovascular Committee of the European Association of Nuclear Medicine (EANM).Imaging for assessment of sudden death risk: current role and future prospects.PET/MR: Yet another Tesla?PET imaging in heart failure: the role of new tracers.Role of PET to evaluate coronary microvascular dysfunction in non-ischemic cardiomyopathies.The role of nuclear cardiac imaging in risk stratification of sudden cardiac death.Positron Emission Tomography-Determined Hyperemic Flow, Myocardial Flow Reserve, and Flow Gradient-Quo Vadis?Myocardial perfusion in patients with non-ischaemic systolic heart failure and type 2 diabetes: a cross-sectional study using Rubidium-82 PET/CT.Comparison of maximal Rubidium-82 activities for myocardial blood flow quantification between digital and conventional PET systems.Role of Myocardial Perfusion Study in Differentiating Ischemic versus Nonischemic Cardiomyopathy Using Quantitative Parameters.Measurement of MBF by PET is ready for prime time as an integral part of clinical reports in diagnosis and risk assessment of patients with known or suspected CAD-PRO.Microvascular function, is there a link to myocardial viability: Is this another piece to the puzzle?Fractional Flow Reserve or Coronary Flow Reserve for the Assessment of Myocardial Perfusion : Implications of FFR as an Imperfect Reference Standard for Myocardial Ischemia
P2860
Q35739686-000359F5-E8C5-4C9F-BE82-D3D0E0889D3FQ36273415-A8FB76EC-2B89-4103-90EA-7CE27FE203D7Q38723494-0B4538A5-2E74-4A12-A31E-A661C97BC1E2Q38813100-C3302B2D-871B-4D32-8A56-1E0DC58B2C31Q38818563-72E19AB6-ADD7-4F2F-8B2D-D322866598D7Q39285234-A389F373-6059-41BD-A2C9-BCA0ECB987D0Q39347577-45A484DC-BB32-4491-A9FA-727DBD76D849Q39548660-41B7C4F6-46D3-4511-AE9F-FF0FEDBAF210Q41024129-A9C9A8A1-292D-454A-91E8-69D11A1D3FC7Q47559357-E94B77AC-64FA-4133-993E-728A8779631BQ48229696-1295E0D7-B4E1-408D-8EB8-10140F8E4D88Q49957330-8311D0EF-E4EC-475F-A5E0-C9B533E1F1C9Q50497994-F80E534F-28A5-4185-B334-430DFFD830F3Q53791828-73E286CF-5CFE-4730-90F9-318FAB6B4F7BQ57174516-15524A3C-1A93-4973-B718-9625AE6849F5
P2860
Quantification of coronary flow reserve in patients with ischaemic and non-ischaemic cardiomyopathy and its association with clinical outcomes.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Quantification of coronary flo ...... iation with clinical outcomes.
@ast
Quantification of coronary flo ...... iation with clinical outcomes.
@en
type
label
Quantification of coronary flo ...... iation with clinical outcomes.
@ast
Quantification of coronary flo ...... iation with clinical outcomes.
@en
prefLabel
Quantification of coronary flo ...... iation with clinical outcomes.
@ast
Quantification of coronary flo ...... iation with clinical outcomes.
@en
P2093
P2860
P50
P356
P1476
Quantification of coronary flo ...... iation with clinical outcomes.
@en
P2093
Courtney R Foster
Jon Hainer
Lynne W Stevenson
Marcelo F Di Carli
Maulik D Majmudar
Negareh Mousavi
Ravi V Shah
Ron Blankstein
Sharmila Dorbala
Swathy Kolli
P2860
P304
P356
10.1093/EHJCI/JEV012
P577
2015-02-25T00:00:00Z